Analysis of K‐ras mutations and expression of cyclooxygenase‐2 and gastrin protein in laterally spreading tumors
暂无分享,去创建一个
A. Terano | J. Imura | T. Fujimori | H. Kawamata | T. Chiba | H. Hiraishi | K. Tominaga | S. Fujii | K. Mukawa | M. Fujita | K. Ichikawa | S. Tomita | Y. Ono | K. Kitajima | J. Takeda | Yoko Chibana
[1] J. Gutkind,et al. Gastrin Stimulates Cyclooxygenase-2 Expression in Intestinal Epithelial Cells through Multiple Signaling Pathways , 2002, The Journal of Biological Chemistry.
[2] C. Paraskeva,et al. Human colorectal adenomas demonstrate a size‐dependent increase in epithelial cyclooxygenase‐2 expression , 2002, The Journal of pathology.
[3] P. Guillou,et al. Interstitial cell cyclooxygenase‐2 expression is associated with increased angiogenesis in human sporadic colorectal adenomas , 2002, The Journal of pathology.
[4] 이석호,et al. Kirsten ras mutations in patients with colorectal cancer: the ‘RASCAL II’ study , 2001, British Journal of Cancer.
[5] T. Ogihara,et al. Laterally spreading tumor: Clinicopathological study in comparison with the depressed type of colorectal tumor , 2001, Journal of gastroenterology and hepatology.
[6] H. Sheng,et al. K-Ras-mediated increase in cyclooxygenase 2 mRNA stability involves activation of the protein kinase B1. , 2001, Cancer research.
[7] E. Gerner,et al. Sulindac sulfone inhibits K-ras-dependent cyclooxygenase-2 expression in human colon cancer cells. , 2000, Cancer research.
[8] T. Fujimori,et al. Relationship between cyclooxygenase-2 expression and K-ras gene mutation in colorectal adenomas. , 2000, Journal of gastroenterology and hepatology.
[9] T. Fujimori,et al. Analysis of K‐ras codon 12 mutations and p53 overexpression in colorectal nodule‐aggregating tumors , 2000, Journal of gastroenterology and hepatology.
[10] M. Bissonnette,et al. Mutational and nonmutational activation of p21ras in rat colonic azoxymethane-induced tumors: effects on mitogen-activated protein kinase, cyclooxygenase-2, and cyclin D1. , 2000, Cancer research.
[11] T. Wang,et al. Progastrin expression predisposes mice to colon carcinomas and adenomas in response to a chemical carcinogen. , 2000, Gastroenterology.
[12] J. Westwick,et al. Oncogenic ras induces gastrin gene expression in colon cancer. , 1998, Gastroenterology.
[13] J. Chiang,et al. K-ras codon 12 mutation determines the polypoid growth of colorectral cancer. , 1998, Cancer research.
[14] A. Norman,et al. Kirsten ras mutations in patients with colorectal cancer: the multicenter "RASCAL" study. , 1998, Journal of the National Cancer Institute.
[15] H. J. Kim,et al. Regulation of growth of human gastric cancer by gastrin and glycine-extended progastrin. , 1997, Gastroenterology.
[16] R. DuBois,et al. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[17] H. Höfler,et al. EXPRESSION OF bcl‐2 AND p53 IN DE NOVO AND EX‐ADENOMA COLON CARCINOMA: A COMPARATIVE IMMUNOHISTOCHEMICAL STUDY , 1996, The Journal of pathology.
[18] T. Wood,et al. Gastrin gene expression is required for the proliferation and tumorigenicity of human colon cancer cells. , 1996, Cancer research.
[19] G. Ciccotosto,et al. Expression, processing, and secretion of gastrin in patients with colorectal carcinoma. , 1995, Gastroenterology.
[20] M. Kondo,et al. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. , 1995, Cancer research.
[21] S Jothy,et al. Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. , 1995, Cancer research.
[22] T. Muto,et al. Polypoid growth and K‐ras codon 12 mutation in coiorectal cancer , 1995, Cancer.
[23] R. Coffey,et al. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. , 1994, Gastroenterology.
[24] S. Maeda,et al. Comparative clinicopathological and immunohistochemical study of ras and p53 in flat and polypoid type colorectal tumours. , 1994, Gut.
[25] S. Maeda,et al. Non‐involvement of ras mutations in flat colorectal adenomas and carcinomas , 1994, International journal of cancer.
[26] S. Kudo,et al. Endoscopic Mucosal Resection of Flat and Depressed Types of Early Colorectal Cancer , 1993, Endoscopy.
[27] R. Koski,et al. Expression of the gastrin gene in the normal human colon and colorectal adenocarcinoma. , 1993, Cancer research.
[28] J. Rehfeld,et al. Expression but incomplete maturation of progastrin in colorectal carcinomas. , 1993, Gastroenterology.
[29] K. Seibert,et al. Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[30] B. Varnum,et al. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. , 1991, The Journal of biological chemistry.
[31] J. Guillem,et al. Rapid detection of ras oncogenes in human tumors: applications to colon, esophageal, and gastric cancer. , 1989, Oncogene.
[32] Y. Nakamura,et al. Genetic alterations during colorectal-tumor development. , 1988, The New England journal of medicine.
[33] B. Crawford,et al. Small nonpolypoid carcinomas of the large intestine , 1983, Cancer.
[34] K. Imai,et al. Increased cyclooxygenase-2 expression in large flat colorectal tumors (laterally spreading tumors) , 2003, Journal of Gastroenterology.
[35] G. Qvigstad,et al. The CCK-2 receptor is located on the ECL cell, but not on the parietal cell. , 2001, Scandinavian journal of gastroenterology.
[36] F. Sundler,et al. Trophic effects of continuous infusion of [Leu15]-gastrin-17 in the rat. , 1990, Gastroenterology.